Alnylam Pharmaceuticals, Inc. ( ALNY) - Key Metrics

ALNY Revenue per Share metrics
Date Revenue per Share Net Income per Share Operating Cash Flow Free Cash Flow per Share
2026Q3 $10.90 $16.19 $2.55 $2.03
2026Q2 $9.69 $1.23 $0.57 $0.31
2026Q1 $8.78 $1.55 $0.53 $0.37
2025Q4 $8.30 $1.41 $1.24 $1.06
2025Q3 $9.50 $1.91 $2.47 $2.38

ALNY Payout ratio and Price per Earnings ratio
Date Payout ratio PE ratio
2026Q3 0% 3.81
2026Q2 0% 61.18
2026Q1 0% 53.37
2025Q4 0% 70.51
2025Q3 0% 59.69

ALNY Free Cash Flow Yield and Dividend Yield
DateFree Cash Flow YieldDividend Yield
2026Q3 0.82% 0%
2026Q2 0.10% 0%
2026Q1 0.11% 0%
2025Q4 0.27% 0%
2025Q3 0.52% 0%

ALNY

Price: $165.60

52 week price:
153.96
479.79

Earnings Per Share: 19.80 USD

P/E Ratio: 8.14

Exchange: NMS

Sector: Healthcare

Industry: Biotechnology

Country: United States

Volume: 712302

Ebitda: -143.6 million

Market Capitalization: 20.9 billion

Links: